SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Fri, 25 Apr · 13:19 IST

Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The specific details of the disclosure (such as the event, transaction, or update being reported) are not captured in the headline itself. Regulation 30 filings typically cover material events like mergers, acquisitions, changes in leadership, financial results, or other corporate actions that could affect investors. Shareholders would need to refer to the full filing or the company's investor communications for the actual content of this disclosure.

Likely market impact

No direct impact on shareholders or stock price can be assessed from the headline alone, as the substance of the disclosure is not visible. Investors should check the detailed filing to understand any material information.